Arthritis Clinical Trials in Portland, OR

16 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease	Phase 2	Novartis Pharmaceuticals	<1 mi
Rehabilitation for Arthritis of The Knee: mainTaining Improvement for Veterans	Phase 3	VA Office of Research and Development	<1 mi
MISHA Post-Market Clinical Study	N/A	Moximed	<1 mi
RA-PRO PRAGMATIC TRIAL	Phase 3	University of Alabama at Birmingham	<1 mi
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study	N/A	Zimmer Biomet	<1 mi
ConsideRAte Study - Splenic Stimulation for RA	N/A	Galvani Bioelectronics	<1 mi
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis	Phase 4	CARE ARTHRITIS LTD.	<1 mi
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis	Phase 2	Avalyn Pharma Inc.	<1 mi
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT	—	Oregon Health and Science University	<1 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry	—	Duke University	<1 mi
Z1 Hip System: Post-Market Clinical Follow Up Study	—	Zimmer Biomet	<1 mi
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).	Phase 1	Novartis Pharmaceuticals	<1 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response	Phase 3	MoonLake Immunotherapeutics AG	<1 mi
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain	Phase 3	Novo Nordisk A/S	<1 mi
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.	Phase 3	AbbVie	<1 mi
Persona Revision Knee System Outcomes	—	Zimmer Biomet	11 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.